Scribe Therapeutics Inc. Common Stock Earnings
The next earnings date for Scribe Therapeutics Inc. Common Stock is December 2, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Scribe Therapeutics Inc. Common Stock Earnings
| 12/02/2026 | $-0.42 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Scribe Therapeutics Inc. Common Stock Earnings: Historical
| 09/02/2026 | After Market | $-3.84 | 38.06% |
More About Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
“Scribe Therapeutics Inc. Common Stock Earnings” Can Refer to the Scribe Therapeutics Inc. Common Stock Earnings Date
Some people say “Scribe Therapeutics Inc. Common Stock earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Scribe Therapeutics Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Scribe Therapeutics Inc. Common Stock Stock on the Earnings Date
If you own Scribe Therapeutics Inc. Common Stock stock (SCTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Scribe Therapeutics Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Scribe Therapeutics Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Scribe Therapeutics Inc. Common Stock Earnings
You can contact us any time if you would like to ask questions about Scribe Therapeutics Inc. Common Stock earnings or anything else related to the stock market.